Electrical storm in an acquired short QT syndrome successfully treated with quinidine

Short QT syndrome (SQTS) is a malignant heart disorder defined by the presence of ventricular arrhythmias causing syncope and sudden cardiac arrest. The prevalence in the pediatric population is 0.05%. Quinidine is an established agent for pharmacological prophylaxis in SQTS patients, but can also t...

Descripción completa

Detalles Bibliográficos
Autores principales: Spartalis, Michael, Livanis, Efthimios, Spartalis, Eleftherios, Tsoutsinos, Alexandros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692974/
https://www.ncbi.nlm.nih.gov/pubmed/31428405
http://dx.doi.org/10.1002/ccr3.2282
_version_ 1783443626780524544
author Spartalis, Michael
Livanis, Efthimios
Spartalis, Eleftherios
Tsoutsinos, Alexandros
author_facet Spartalis, Michael
Livanis, Efthimios
Spartalis, Eleftherios
Tsoutsinos, Alexandros
author_sort Spartalis, Michael
collection PubMed
description Short QT syndrome (SQTS) is a malignant heart disorder defined by the presence of ventricular arrhythmias causing syncope and sudden cardiac arrest. The prevalence in the pediatric population is 0.05%. Quinidine is an established agent for pharmacological prophylaxis in SQTS patients, but can also terminate an electrical storm.
format Online
Article
Text
id pubmed-6692974
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-66929742019-08-19 Electrical storm in an acquired short QT syndrome successfully treated with quinidine Spartalis, Michael Livanis, Efthimios Spartalis, Eleftherios Tsoutsinos, Alexandros Clin Case Rep Clinical Images Short QT syndrome (SQTS) is a malignant heart disorder defined by the presence of ventricular arrhythmias causing syncope and sudden cardiac arrest. The prevalence in the pediatric population is 0.05%. Quinidine is an established agent for pharmacological prophylaxis in SQTS patients, but can also terminate an electrical storm. John Wiley and Sons Inc. 2019-06-23 /pmc/articles/PMC6692974/ /pubmed/31428405 http://dx.doi.org/10.1002/ccr3.2282 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Images
Spartalis, Michael
Livanis, Efthimios
Spartalis, Eleftherios
Tsoutsinos, Alexandros
Electrical storm in an acquired short QT syndrome successfully treated with quinidine
title Electrical storm in an acquired short QT syndrome successfully treated with quinidine
title_full Electrical storm in an acquired short QT syndrome successfully treated with quinidine
title_fullStr Electrical storm in an acquired short QT syndrome successfully treated with quinidine
title_full_unstemmed Electrical storm in an acquired short QT syndrome successfully treated with quinidine
title_short Electrical storm in an acquired short QT syndrome successfully treated with quinidine
title_sort electrical storm in an acquired short qt syndrome successfully treated with quinidine
topic Clinical Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692974/
https://www.ncbi.nlm.nih.gov/pubmed/31428405
http://dx.doi.org/10.1002/ccr3.2282
work_keys_str_mv AT spartalismichael electricalstorminanacquiredshortqtsyndromesuccessfullytreatedwithquinidine
AT livanisefthimios electricalstorminanacquiredshortqtsyndromesuccessfullytreatedwithquinidine
AT spartaliseleftherios electricalstorminanacquiredshortqtsyndromesuccessfullytreatedwithquinidine
AT tsoutsinosalexandros electricalstorminanacquiredshortqtsyndromesuccessfullytreatedwithquinidine

Ejemplares similares